A weekly collection of links to interesting things curated by Colin Wright. Experimental mRNA Vaccines Gain Steam With Promising Cancer Trial Results Pharmaceutical giants Moderna and Merck announced promising results from a clinical trial testing a combined treatment of an mRNA vaccine and immunotherapy for skin cancer. Melanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower chances of cancer recurrence and spread, as well as higher survival rates, than those who received Keytruda alone.
Curiosity Weekly
Curiosity Weekly
Curiosity Weekly
A weekly collection of links to interesting things curated by Colin Wright. Experimental mRNA Vaccines Gain Steam With Promising Cancer Trial Results Pharmaceutical giants Moderna and Merck announced promising results from a clinical trial testing a combined treatment of an mRNA vaccine and immunotherapy for skin cancer. Melanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower chances of cancer recurrence and spread, as well as higher survival rates, than those who received Keytruda alone.